|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Staking revenue | |||||
| Product sales and other revenue | |||||
| Product | |||||
| Total product sales and other revenue | |||||
| Other revenue | |||||
| Total revenue | |||||
| Cost of revenue | |||||
| Cost of revenue | |||||
| Gross profit (loss) | |||||
| Operating expenses | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Amortization expense | |||||
| Goodwill and fixed asset impairment | |||||
| Fixed asset impairment | |||||
| Unrealized loss on digital assets and digital assets receivable | |||||
| Realized loss on digital assets | |||||
| Unrealized loss on digital assets fund investment | |||||
| Realized gain on digital asset derivatives | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Nonoperating income | |||||
| Interest expense, net | |||||
| Foreign exchange gain (loss) and other income | |||||
| Other income, net | |||||
| Change in fair value of derivative liability | |||||
| Loss on derivative liability | |||||
| Financing costs | |||||
| Nonoperating income, net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Other comprehensive loss | |||||
| Foreign currency translation adjustments | |||||
| Comprehensive loss | |||||
| Loss per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
